Monday, October 13, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Fri, 04 Jul 2008 02:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/113960.php
ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease ActivityTeva Pharmaceutical Industries Ltd. (NASDAQ: Teva) and Antisense Therapeutics Ltd. (ASX: ANP) announced that ATL/TV1102, a novel, anti-sense drug, significantly reduced disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). A randomized, double-blind, placebo-controlled Phase IIa study met its primary endpoint showing a significant reduction by 54.4% (p=0.
Click here for full Story
http://www.medicalnewstoday.com/articles/113960.php
Bookmark this news story online:
Add ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to BlinkListAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to DeliciousAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to DiggAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to FarkAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to FurlAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to BlogarithmAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to MeneameAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to My Yahoo!Add ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to ReddItAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to ShadowsAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to SimpyAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to SpurlAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Sync2ItAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to MagnoliaAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to NewsVineAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Ask Jeeves
Add ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Raw SugarAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to DiigoAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to NetVouzAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Stumble UponAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to SegnaloAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Google BookmarksAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Microsoft LiveAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to BlogMarksAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to WinkAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to TechnoratiAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Feed Me LinksAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to LinkaGoGoAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to BlueDotAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Mister WongAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to TailRankAdd ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet Solvents May Cause Brain Disorders, But Rehabilitation Is Possible
bullet Is Couple Therapy Better Than Individual Psychotherapy In Alcoholism?
bullet Memory Improves If Neurons Are New
bullet Reason For Body's Response To Borrelia Discovered
bullet Gene Determines Rapidity Of Ejaculation In Men
bullet At ASPS Annual Meeting: Innovative 'No Breast Implant' Procedure
bullet Patients Who Recover From Coma But Cannot Communicate Feel Pain
bullet A New Improved Gene Therapy Can Be The First Treatment For Machado-Joseph Disease
bullet Phase III Study Showed Rituxan In Combination With Chemotherapy Improved Progression-Free Survival In Patients With Relapsed Chronic Leukemia
bullet Early Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery Disease
bullet Nobel Prize For Discovery Of Green Fluorescent Protein Won By MBL Scientist Osamu Shimomura
bullet Scientists To Explore Chemical Reactions In Extreme Conditions
bullet Heart Transplantation Programme At Harefield Hospital To Undergo Review
bullet Maple Leaf Foods Update On Its Bartor Road Facility And Positive Test Results For Listeria
bullet High Risk Offender Charged With Assaulting A Women In Her Home, Calgary, Canada
bullet Pregnancy Does Not Affect Mother's Cognitive Function, New Study
bullet Risk Factors Outside Of AAP Guidelines Identify More Preemies Needing RSV Prophylaxis
bullet Controversial Injections Examined At ASPS Annual Meeting
bullet Urban Earthquakes, Nuclear Bombs And 9/11: New York Seismologist Honored For Work Local And Global
bullet Body Contouring: Selecting Appropriate Massive Weight Loss Patients Critical
bullet Natural Fingerprints In Coal Used To Track Mercury Emissions
bullet Biological Alternatives To Chemical Pesticides
bullet NCAR Launches Intensive Study Into Future Hurricane Risk
bullet UNC Receives $8.5 Million For New Public Health Preparedness Research Center
bullet Clue To Genetic Cause Of Fatal Birth Defect
 
© 2007 Verge Systems